Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilenka Rj Thynne

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Australian Prescriber|October 23, 2020
Harms and benefits of sodium-glucose co-transporter 2 inhibitorsThomas Chesterman, Tilenka Rj Thynne
Australian Prescriber|December 6, 2023
Limitations of randomised controlled trials as evidence of drug safetyTilenka Rj Thynne, Genevieve M Gabb
The Cochrane Database of Systematic Reviews|January 19, 2019
Methotrexate for psoriatic arthritisTom D Wilsdon, Samuel L Whittle, Tilenka Rj Thynne, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Australian Prescriber|October 23, 2020
Harms and benefits of sodium-glucose co-transporter 2 inhibitorsThomas Chesterman, Tilenka Rj Thynne
Australian Prescriber|December 6, 2023
Limitations of randomised controlled trials as evidence of drug safetyTilenka Rj Thynne, Genevieve M Gabb
The Cochrane Database of Systematic Reviews|January 19, 2019
Methotrexate for psoriatic arthritisTom D Wilsdon, Samuel L Whittle, Tilenka Rj Thynne, et al.
Pageof 1